Effect of a Six-week Integrated Attention Training Program on the Cognitive Functions of Older Adults With Co-occurring Anxiety Symptoms and Subjective Cognitive Complaints
- Disease/Condition
- Anxiety
- Drug/Device/Intervention
- Integrated Attention Training Program
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Hong Kong Baptist University
- Location
- Hong Kong, China
- Phase
- N/A
- Start date
- Jul 01, 2023
- End date
- Jun 30, 2025
- Enrollment
- 120 participants
Attention - Digit Span Forward Task,Attention - Chinese Trail Making Test - Part A (CTMT-A),Executive function - Category Verbal Fluency Test (CVFT),Executive function - Digit Span Backwards Task,Executive function - Chinese Trail Making Test - Part B (CTMT-B),Anxiety symptoms,Level of inflammation,Level of inflammation,Level of inflammation,Level of inflammation
The goal of this single-blind randomized control trial is to compare a 6-week Integrated
 Attention Training Program (IATP) and health education in older people with co-occurrence of
 anxiety symptoms and subjective cognitive decline (SCC).
 
 The study aims to answer if a 6-week Integrated Attention Training Program (IATP) will
 improve cognitive, anxiety, and level of pro-inflammatory biomarkers in this high-risk group.
 
 Older adults with co-occurring anxiety and SCC will be recruited to participate in a 6-week
 single-blind randomized controlled trial. IATP group (Intervention group) will undergo
 attention and functional training. Control group will receive health education.
 
 Investigators will compare the IATP with health education to see if cognitive function,
 anxiety symptoms, and level of pro-inflammatory biomarkers in comparison to health education
 will improved after intervention and over 24 weeks.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06063265
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06063265 through Pure Global AI's free database. This phase not specified trial is sponsored by Hong Kong Baptist University and is currently Recruitment Completed. The study focuses on Anxiety. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.